Top

Journal of Interventional Cardiac Electrophysiology

Published in:

01-06-2012 | Perspectives

Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation

Authors: Gustavo Lopera, Gerald A. Beathard, Jose Exaire, Roger Carrillo

Published in: Journal of Interventional Cardiac Electrophysiology | Issue 1/2012

Excerpt

Cardiovascular disease is the leading cause of death in patients with end-stage renal disease (ESRD). In the United States Renal Data System database, 25–29.7% of cardiac deaths are attributable to arrhythmic mechanisms [1, 2]. Ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) likely remain the most common initiating and potentially reversible mechanisms of out-of-hospital sudden cardiac death (SCD). Defibrillation is the only predictably effective therapy for reverting VF and pulseless VT to an effective rhythm for restoration of blood flow [3]. The expanding indications of implantable cardioverter-defibrillator (ICD) therapy for primary and secondary prevention of SCD have significantly increased the patient population with cardiac implantable electronic devices (CIEDs) [4]. …

US Renal Data System: USRDS 2006 Annual Data Report. Bethesda,MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006.

Herzog, C. A., Mangrum, J. M., & Passman, R. (2008). Sudden cardiac death and dialysis patients. Seminars in Dialysis, 21(4), 300–307.PubMedCrossRef

Lopera, G., & Myerburg, R. (2010). Indications for implantable cardioverter-defibrillators. In G. Yan & P. Kowey (Eds.), Management of cardiac arrhythmias (pp. 283–304). Chapter 13.

ACC/AHA/HRS. (2008). Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 51, e1–e62.CrossRef

Korantzopoulos, P., Liu, T., Li, L., Goudevenos, J. A., & Li, G. (2009). Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis. Europace, 11, 1469–1475.PubMedCrossRef

Cuculich, P. S., Sánchez, J. M., Kerzner, R., Greenberg, S. L., Sengupta, J., Chen, J., Faddis, M. N., Gleva, M. J., Smith, T. W., & Lindsay, B. D. (2007). Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing and Clinical Electrophysiology, 30, 207–213.PubMedCrossRef

Amin, M. S., Fox, A. D., Kalahasty, G., Shepard, R. K., Wood, M. A., & Ellenbogen, K. A. (2008). Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis. Journal of Cardiovascular Electrophysiology, 19, 1275–1280.PubMedCrossRef

Robin, J., Weinberg, K., Tiongson, J., Carnethon, M., Reddy, M., Ciaccio, C., Quadrini, M., Hsu, J., Fan, J., Choi, P., Kadish, A., Goldberger, J., & Passman, R. (2006). Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm, 3(10), 1196–1201. Epub 2006 Jul 8.PubMedCrossRef

Goldenberg, I., & Moss, A. J. (2008). Implantable cardioverter defibrillator efficacy and chronic kidney disease: competing risks of arrhythmic and nonarrhythmic mortality. Journal of Cardiovascular Electrophysiology, 19(12), 1281–1283.PubMedCrossRef

10.

Turakhia, M. P., Varosy, P. D., Lee, K., Tseng, Z. H., Lee, R., Badhwar, N., Scheinman, M., Lee, B. K., & Olgin, J. E. (2007). Impact of renal function on survival in patients with implantable cardioverter-defibrillators. Pacing and Clinical Electrophysiology, 30(3), 377–384.PubMedCrossRef

11.

Hiremath, S., Punnam, S. R., Brar, S. S., Goyal, S. K., Gardiner, J. C., Shah, A. J., & Thakur, R. K. (2010). Implantable defibrillators improve survival in end-stage renal disease: results from a multi-center registry. American Journal of Nephrology, 32(4), 305–310.PubMedCrossRef

12.

Manolis, A. S. (1994). Transvenous endocardial cardioverter defibrillator systems. Is the future here? Archives of Internal Medicine, 154(6), 617–622.PubMedCrossRef

13.

Zipes, D. P., & Roberts, D. (1995). Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation, 92(1), 59–65.PubMed

14.

Saksena, S. (1993). Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. The PCD investigators and participating institutions. Pacing and Clinical Electrophysiology, 16(1 Pt 2), 202–207.PubMedCrossRef

15.

van Rooden, C. J., Molhoek, S. G., Rosendaal, F. R., Schalij, M. J., Meinders, A. E., & Huisman, M. V. (2004). Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. Journal of Cardiovascular Electrophysiology, 15(11), 1258–1262.PubMedCrossRef

16.

Lickfett, L., Bitzen, A., Arepally, A., Nasir, K., Wolpert, C., Jeong, K. M., Krause, U., Schimpf, R., Lewalter, T., Calkins, H., Jung, W., & Lüderitz, B. (2004). Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace, 6(1), 25–31.PubMedCrossRef

17.

Haghjoo, M., Nikoo, M. H., Fazelifar, A. F., Alizadeh, A., Emkanjoo, Z., & Sadr-Ameli, M. A. (2007). Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Europace, 9(5), 328–332. Epub 2007 Mar 16.PubMedCrossRef

18.

Teruya, T. H., Abou-Zamzam, A. M., Jr., Limm, W., Wong, L., & Wong, L. (2003). Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers. Annals of Vascular Surgery, 17(5), 526–529.PubMedCrossRef

19.

Korzets, A., Chagnac, A., Ori, Y., Katz, M., & Zevin, D. (1991). Subclavian vein stenosis, permanent cardiac pacemakers and the haemodialysed patient. Nephron, 58(1), 103–105.PubMedCrossRef

20.

Lin, G., Nishimura, R. A., Connolly, H. M., Dearani, J. A., Sundt, T. M., 3rd, & Hayes, D. L. (2005). Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. Journal of the American College of Cardiology, 45(10), 1672–1675.PubMedCrossRef

21.

Iskandar, S. B., Ann Jackson, S., Fahrig, S., Mechleb, B. K., & Garcia, I. D. (2006). Tricuspid valve malfunction and ventricular pacemaker lead: case report and review of the literature. Echocardiography, 23(8), 692–697.PubMedCrossRef

22.

Paniagua, D., Aldrich, H. R., Lieberman, E. H., Lamas, G. A., & Agatston, A. S. (1998). Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. The American Journal of Cardiology, 82(9), 1130–1132.PubMedCrossRef

23.

Baddour, L. M., Epstein, A. E., Erickson, C. C., Knight, B. P., Levison, M. E., Lockhart, P. B., Masoudi, F. A., Okum, E. J., Wilson, W. R., Beerman, L. B., Bolger, A. F., Estes, N. A., 3rd, Gewitz, M., Newburger, J. W., Schron, E. B., & Taubert, K. A. (2010). Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American Heart Association. Circulation, 121(3), 458–477.PubMedCrossRef

24.

Bloom, H., Heeke, B., Leon, A., Mera, F., Delurgio, D., Beshai, J., & Langberg, J. (2006). Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing and Clinical Electrophysiology, 29(2), 142–145.PubMedCrossRef

25.

Baman, T. S., Gupta, S. K., Valle, J. A., & Yamada, E. (2009). Risk factors for mortality in patients with cardiac device-related infection. Circulation. Arrhythmia and Electrophysiology, 2(2), 129–134.PubMedCrossRef

26.

Lekkerkerker, J. C., van Nieuwkoop, C., Trines, S. A., van der Bom, J. G., Bernards, A., van de Velde, E. T., Bootsma, M., Zeppenfeld, K., Jukema, J. W., Borleffs, J. W., Schalij, M. J., & van Erven, L. (2009). Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart, 95(9), 715–720. Epub 2008 Nov 26.PubMedCrossRef

27.

Uslan, D. Z. (2008). Infections of electrophysiologic cardiac devices. Expert Review of Medical Devices, 5(2), 183–195. Review.PubMedCrossRef

28.

Greenspon, A. J., Rhim, E. S., Mark, G., Desimone, J., & Ho, R. T. (2008). Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus. Pacing and Clinical Electrophysiology, 31(5), 548–553.PubMedCrossRef

29.

Wilkoff, B. L., Love, C. J., Byrd, C. L., Bongiorni, M. G., Carrillo, R. G., Crossley, G. H., 3rd, Epstein, L. M., Friedman, R. A., Kennergren, C. E., Mitkowski, P., Schaerf, R. H., Wazni, O. M., & Heart Rhythm Society; American Heart Association. (2009). Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm, 6(7), 1085–1104.PubMedCrossRef

30.

Sarnak, M. J., & Jaber, B. L. (2000). Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney International, 58(4), 1758–1764.PubMedCrossRef

31.

Asif, A., Carrillo, R., Garisto, J.D., Lopera, G., Ladino, M., Barakat, U., Eid, N., Salman, L. (2010). Epicardial Cardiac rhythm devices for dialysis patients: minimizing the risk of infection and preserving central veins. Seminars in Dialysis.

32.

Gabor, S., Prenner, G., Wasler, A., Schweiger, M., Tscheliessnigg, K. H., & Smolle-Jüttner, F. M. (2005). A simplified technique for implantation of left ventricular epicardial leads for biventricular re-synchronization using video-assisted thoracoscopy (VATS). European Journal of Cardio-Thoracic Surgery, 28(6), 797–800.PubMedCrossRef

33.

Cannon, B. C., Friedman, R. A., Fenrich, A. L., Fraser, C. D., McKenzie, E. D., & Kertesz, N. J. (2006). Innovative techniques for placement of implantable cardioverter-defibrillator leads in patients with limited venous access to the heart. Pacing and Clinical Electrophysiology, 29(2), 181–187.PubMedCrossRef

34.

Bhakta, M., Obioha, C. C., Sorajja, D., Srivathsan, K., Arabia, F. A., Devaleria, P. A., Jaroszewski, D. E., Scott, L. R., & Altemose, G. T. (2010). Nontraditional implantable cardioverter defibrillator placement in adult patients with limited venous access: a case series. Pacing and Clinical Electrophysiology, 33(2), 217–225.PubMedCrossRef

35.

Molina, J. E., & Benditt, D. G. (2004). An epicardial subxiphoid implantable defibrillator lead: superior effectiveness after failure of standard implants. Pacing and Clinical Electrophysiology, 27(11), 1500–1506.PubMedCrossRef

36.

Bardy, G. H., Smith, W. M., Hood, M. A., Crozier, I. G., Melton, I. C., Jordaens, L., Theuns, D., Park, R. E., Wright, D. J., Connelly, D. T., Fynn, S. P., Murgatroyd, F. D., Sperzel, J., Neuzner, J., Spitzer, S. G., Ardashev, A. V., Oduro, A., Boersma, L., Maass, A. H., Van Gelder, I. C., Wilde, A. A., van Dessel, P. F., Knops, R. E., Barr, C. S., Lupo, P., Cappato, R., & Grace, A. A. (2010). An entirely subcutaneous implantable cardioverter-defibrillator. The New England Journal of Medicine, 363(1), 36–44.PubMedCrossRef

Title: Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation
Authors: Gustavo Lopera
Gerald A. Beathard
Jose Exaire
Roger Carrillo
Publication date: 01-06-2012
Publisher: Springer US
Published in: Journal of Interventional Cardiac Electrophysiology / Issue 1/2012
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI: https://doi.org/10.1007/s10840-011-9649-y

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2012

Clinical features of patients with left atrial thrombus undergoing anticoagulant therapy

Incidence and clinical predictors of low defibrillation safety margin at time of implantable defibrillator implantation

Safety and efficacy of the remote magnetic navigation for ablation of ventricular tachycardias—a systematic review

Feasibility and efficacy of minimally invasive stand-alone surgical ablation of atrial fibrillation. A single-center experience

Sleep apnea does not predict atrial flutter recurrence after atrial flutter ablation

Natural history of the Sprint Fidelis lead: survival analysis from a large single-center study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page